Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q1 2015 (← Previous) (Next →)

Filing Date: May 15, 2015

Total Value: $343M (100.0% shares, 0.0% debt)

Holdings (17)

Medivation, Inc. 82.6%
Value $284M Shares 2,198,919 Est. Cost $49.20 Unrealized
Ampio Pharmaceuticals Inc. 7.4%
Value $25.51M Shares 3,388,322 Est. Cost $6.03 Unrealized
Synthetic Biologics Inc. 2.2%
Value $7.448M Shares 3,400,816 Est. Cost $1.48 Unrealized
Alcobra Ltd 1.8%
Value $6.279M Shares 1,115,315 Est. Cost $7.08 Unrealized
Newlink Genetics Corp 1.6%
Value $5.604M Shares 102,437 Est. Cost $27.98 Unrealized
Advaxis Inc. 1.2%
Value $3.971M Shares 275,000 Est. Cost $14.44 Unrealized
Keryx Biopharmaceuticals Inc. 0.7%
Value $2.546M Shares 200,000 Est. Cost $10.21 Unrealized
Bio Blast Pharma Ltd 0.6%
Value $2.029M Shares 338,110 Est. Cost $7.27 Unrealized
ALDX Aldeyra Therapeutics Inc 0.4%
Value $1.382M Shares 135,800 Est. Cost $10.20 Unrealized 0.0%
Lion Biotechnologies Inc 0.4%
Value $1.211M Shares 100,000 Est. Cost $12.11 Unrealized
Advaxis Inc. 0.3%
Value $1.17M Shares 112,500 Est. Cost $10.40 Unrealized
PlasmaTech Biopharmaceutical 0.2%
Value $669K Shares 213,100 Est. Cost $3.14 Unrealized
Galmed Pharmaceuticals Ltd 0.2%
Value $612K Shares 65,000 Est. Cost $11.48 Unrealized
OHR Pharmaceutical Inc 0.2%
Value $521K Shares 205,000 Est. Cost $2.54 Unrealized
Evoke Pharma Inc 0.1%
Value $380K Shares 53,839 Est. Cost $7.06 Unrealized
Zosano Pharma Corp 0.1%
Value $202K Shares 20,000 Est. Cost $10.10 Unrealized
Aptose Biosciences Inc 0.0%
Value $108K Shares 20,000 Est. Cost $5.40 Unrealized